Genetic testing for colorectal cancer: What is it?

Written in association with: Mr Ashish Sinha
Published:
Edited by: Aoife Maguire

The risk of colorectal cancer can be increased significanty due to genetic factors. Leading consultant colorectal and general surgeon, Mr Ashish Sinha, explains genetic testing for the disease.

 

What is genetic testing for colorectal cancer, and how does it aid in preventing this type of cancer?

 

All cancers have a genetic component. As we age, errors in our DNA can occur, leading to cancer development, including colorectal cancer, which is commonly seen in older individuals.

 

 

 

 

Genetics plays a crucial role in identifying colorectal cancer at an early age, making genetic testing particularly significant. It allows us to tailor treatment plans for patients based on their genetic profile. Additionally, if we diagnose colorectal cancer resulting from an underlying genetic predisposition, we can offer screening to the patient's close relatives.

 

Which specific genetic markers or mutations are commonly tested for in individuals at risk of colorectal cancer?

 

Researchers continue to discover genes associated with colorectal cancer development.

 

Currently, two main syndromes are prominent in our investigation. One is linked to polyps; individuals with a higher number of polyps are at an increased risk of developing colorectal cancer.

 

The second is Lynch syndrome, which encompasses several diseases caused by up to five different genes. Importantly, Lynch syndrome can affect organs beyond the bowel.

 

How is the colorectal cancer genetic test performed?

 

Genetic testing for colorectal cancer is typically performed in a laboratory setting. Following a colonoscopy, an endoscopist collects a biopsy sample. The laboratory-based tests specifically search for genetic mutations within the tumour to determine the individual's genetic risk.

 

What are the implications and advantages of undergoing genetic testing for colorectal cancer in terms of prevention and early detection?

 

The most significant advantage of genetic testing is early detection. If colorectal cancer is identified at an early stage, the chances of successful treatment and cure are significantly higher. Therefore, it's essential to consider colorectal cancer screening if any related symptoms, such as changes in bowel habits, are noticed.

 

How do the results of genetic testing guide personalised risk assessment and screening recommendations for individuals with a higher risk of developing colorectal cancer?

 

Genetic testing plays a critical role in assessing individual risk. By analysing relevant data, such as genetic risk, polyp types, and early-onset cases, we can determine the appropriate frequency of surveillance and recommend prophylactic surgery for at-risk organs. The ultimate goal is cancer prevention. In cases of established colorectal cancer, genetic test results can also help inform additional or adjuvant treatment strategies.

 

 

 

 

 

If you require genetic testing and would like to book a consultation with Mr Sinha, simply visit his Top Doctors profile today.

By Mr Ashish Sinha
Colorectal surgery

Mr Ashish Sinha is a highly skilled and trusted consultant colorectal and general surgeon with over 15 years’ of experience based in Central and West London. He is a consultant surgeon at the world-renowned St Mark’s – The National Bowel Hospital, London and a senior clinical lecturer at Imperial College, London. He has expertise in inherited colorectal cancer syndromes and polyposis and is the consultant surgeon to the St Mark’s Centre for Familial Cancer.  

He performs surgery for a wide range of conditions focusing principally on colorectal cancer, polyposis and other benign colonic conditions like diverticular disease. He typically performs minmally invasive or laparoscopic surgery. He offers laser surgery for treatment of common proctology conditions such as haemorrhoids, fistula and pilonidal sinus, as well as providing diagnostic colonoscopy for colorectal cancer prevention.

His surgical practice covers the full aspect of colorectal surgery including stoma reversal, inflammatory bowel disease (IBD) surgery including colitis and Crohn’s diseaseprolapse surgery and excision of skin tags and warts. Additionally, he offers surgical treatment for conditions including hernia (inguinal/incisional, stoma related and abdominal wall), lumps and bumps excision and emergency treatment such as appendicectomy and abscess drainage.  

Mr Sinha was awarded a Bachelor of Medicine and Bachelor of Surgery (BMBS) degree from the University of Nottingham in 2004. He undertook further training in general and colorectal surgery in the South East Thames Region, London surgical rotation. His research thesis into inherited colorectal cancers and cancer genetics over two years at the Polyposis Registry, St Mark’s Hospital, culminated in him being awarded a MD from Imperial College, London.

His work has been published in several peer-reviewed journals and he continues his research work, concentrating on inherited colorectal cancer syndromes, emergency general surgery in elderly patients and minimally invasive surgery. 
 
He is a member of several medical organisations, including the International Society for Inherited Gastrointestinal Tumours and St Mark’s Association.

View Profile

Overall assessment of their patients


  • Related procedures
  • Gastroscopy
    Polypectomy
    Laparoscopy
    Pelvic floor reconstructive surgery
    Endoscopy
    Colonoscopy
    Robotic surgery
    Gallstones
    Rectal surgery
    Anal fistula surgery
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.